Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Sotera Health (SHC) Return on Sales (2020 - 2025)

Historic Return on Sales for Sotera Health (SHC) over the last 6 years, with Q3 2025 value amounting to 0.16%.

  • Sotera Health's Return on Sales rose 1000.0% to 0.16% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.05%, marking a year-over-year decrease of 100.0%. This contributed to the annual value of 0.04% for FY2024, which is 100.0% down from last year.
  • According to the latest figures from Q3 2025, Sotera Health's Return on Sales is 0.16%, which was up 1000.0% from 0.03% recorded in Q2 2025.
  • In the past 5 years, Sotera Health's Return on Sales ranged from a high of 0.17% in Q2 2021 and a low of 1.27% during Q4 2022
  • Moreover, its 5-year median value for Return on Sales was 0.06% (2024), whereas its average is 0.0%.
  • Its Return on Sales has fluctuated over the past 5 years, first plummeted by -14200bps in 2022, then soared by 14000bps in 2023.
  • Quarter analysis of 5 years shows Sotera Health's Return on Sales stood at 0.15% in 2021, then plummeted by -952bps to 1.27% in 2022, then soared by 110bps to 0.12% in 2023, then tumbled by -66bps to 0.04% in 2024, then surged by 266bps to 0.16% in 2025.
  • Its last three reported values are 0.16% in Q3 2025, 0.03% for Q2 2025, and 0.05% during Q1 2025.